A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism

European Journal of Human Genetics

Volumn 11, Issue 3, 2003, Pages 225-231

  Njajou, Omer T ^a   Houwing Duistermaat, Jeanine ^a   Osborne, Richard H ^b   Vaessen, Norbert ^a   Vergeer, Jeanette ^a   Herringa, Jan ^a   Pols, Huibert A P ^a   Hofman, Albert ^a   van Duijn, Cornelia M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

C282Y; Elderly; H63D; Hemochromatosis; HFE; Iron; Penetrance; Screening

Indexed keywords

FERRITIN; HFE PROTEIN; IRON; TRANSFERRIN;

ADULT; AGING; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENETIC PARAMETERS; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HERITABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRON BLOOD LEVEL; IRON METABOLISM; IRON STORAGE; MALE; MORBIDITY; POPULATION GENETICS; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TRANSFERRIN BLOOD LEVEL; WILD TYPE;

AGED; ALLELES; ELECTROPHORESIS, AGAR GEL; FEMALE; FERRITINS; GENE FREQUENCY; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; SENSITIVITY AND SPECIFICITY; TRANSFERRIN;

NUCLEOPOLYHEDROVIRUS;

EID: 0037366790     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200955     Document Type: Article

References (30)

1. Bhavnani M, Lloyd D, Bhattacharyya A, Marples J, Elton P, Worwood M: Screening for genetic hemochromatosis in blood samples with raised alanine aminotransferase. Gut 2000; 46: 707-710.
2. Powell LW, Jazwinska E, Halliday JW: Primary iron overload; in Brock JH, Halliday JW, Pippard MJ, Powell LW (eds): Iron metabolism in health and disease. London, WB Saunders, 1994; pp 227-270.
3. Edwards CQ, Griffen LM, Goldgar D et al: Prevalence of hemochromatosis among 11605 presumably healthy blood donors. N Engl J Med 1988; 318: 1355-1362.
4. De Villiers JN, Hillerman R, Loubser L, Kotze JM: Spectrum of mutations in the HFE gene implicated in hemochromatosis and porphyria. Hum Mol Genet 1999; 8: 1517-1522.
5. Feder JN, Gnirke A, Thomas W et al: A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996; 13: 399-408.
6. Jouanolle AM, Gandon G, Jezequel P et al: Haemochromatosis and HLA-H. Nat Genet 1996; 14: 251-252.
7. de Valk B, Witlox RS, van der Schouw YT, Marx JJ: Biochemical expression of heterozygous hereditary hemochromatosis. Eur J Intern Med 2000; 11: 317-321.
8. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T: Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359: 211-218.
9. Poullis A, Moodie SJ, Maxwell JD: Clinical haemochromatosis in HFE mutation carriers (Letter). Lancet 2002; 360: 411.
10. Cox T, Rochette J, Camaschella C, Walker A, Robson K: Clinical haemochromatosis in HFE mutation carriers (Letter). Lancet 2002; 360:412.
11. Allen KJ, Warner B, Delatycki MB: Clinical haemochromatosis in HFE mutation carriers (Letter). Lancet 2002; 360: 412-413.
12. Basset ML, Wilson SR, Cavanaugh JA: Penetrance of HFE-related hemochromatosis in perspective. Hepatology 2002; 36: 500-503.
13. Rossi E, Bulsara MK, Olynyl JK, Cullen DJ, Summerville L, Powell LW: Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. Clin Chem 2001; 47: 202-208.
14. Whitfield JB, Cullen LM, Jazwinska EC et al: Effects of HFE C282Y and H63D polymorphism and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 2000; 66: 1246-1258.
15. Porto G et al: Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload. Eur J Haematol 2001; 67: 110-118.
16. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP: Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996; 335: 1799-1805.
17. Datz C, Haas T, Rinner H, Sandhoffer F, Patsch W, Paulweber B: Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency? Clin Chem 1998; 44: 2429-2432.
18. Adams PC: Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 1994; 45: 146-149.
19. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW: A population based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718-724.
20. Rossi E, Olynyk JK, Cullen DJ, Papadopoulos G, Bulsara M, Summerville L, Powell LW: Compound heterozygous hemochromatosis genotype predicts iron and erythrocyte indices in women. Clin Chem 2000; 46: 162-166.
21. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA: Determinants of diseases and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991; 4: 403-422.
22. McLaren CE et al: Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998; 114: 543-549.
23. Bergmeyer HU, Horder M, Rej R: International Federation of Clinical Chemistry (IFCC) Scientific Committee Analytical Section: approved recommendation on IFCC methods for the measurements of catalytic concentration of enzymes. J Clin Chem Clin Biochem 1986; 24: 481-510.
24. Holtzman NA, Marteau TM: Will genetics revolutionize medicine? N Engl J Med 2000; 343: 141-144.
25. Wald NJ, Hackshaw AK, Frost CD: When can a risk factor be used as a worthwhile screening test? BMJ 1999; 319: 1562-1565.
26. Baer DM, Simons JL, Staples RL: Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 1995; 98: 464-468.
27. Cullen LM, Summerville L, Glassick TV, Crawford DHG, Powell LW, Jazwinska EC: Neonatal screening for the hemochromatosis defect. Blood 1997; 90: 4236-4237.
28. Willis G, Wimperis JZ, Smith KC, Fellows IW, Jennnings BA: Haemochromatosis gene C282Y homozygotes in an elderly male population. Lancet 1999; 354: 221-222.
29. Burt MJ. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 1998; 43: 830-836.
30. Jazwinska EC, Cullen LM, Busfield F et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14: 249-251.